Reply

We are grateful to Mazzarelli and colleagues for their input about our recent paper showing an increase in the prevalence of nonalcoholic steatohepatitis (NASH) among candidates for liver transplantation in the United States.1,2 As we have shown, the impact of NASH to the overall burden of chronic liver disease in the United States is steadily growing so that NASH is currently the second most common indication for transplantation in patients with and without hepatocellular carcinoma (HCC), and the first in some large subgroups, such as women without HCC or older patients.
Source: Clinical Gastroenterology and Hepatology - Category: Gastroenterology Authors: Tags: Letter to the Editor Source Type: research